Kourosh Lotfi

2.6k total citations
54 papers, 968 citations indexed

About

Kourosh Lotfi is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Kourosh Lotfi has authored 54 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 27 papers in Genetics and 24 papers in Molecular Biology. Recurrent topics in Kourosh Lotfi's work include Chronic Lymphocytic Leukemia Research (21 papers), Chronic Myeloid Leukemia Treatments (17 papers) and Acute Myeloid Leukemia Research (13 papers). Kourosh Lotfi is often cited by papers focused on Chronic Lymphocytic Leukemia Research (21 papers), Chronic Myeloid Leukemia Treatments (17 papers) and Acute Myeloid Leukemia Research (13 papers). Kourosh Lotfi collaborates with scholars based in Sweden, Norway and Finland. Kourosh Lotfi's co-authors include Curt Peterson, Freidoun Albertioni, Juan E. Grunwald, Henrik Gréen, Ingrid Jakobsen Falk, Staffan Eriksson, Tatjana Spasokoukotskaja, Gunnar Juliusson, Sussanne Börjeson and Peter Söderkvist and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Cancer Research.

In The Last Decade

Kourosh Lotfi

52 papers receiving 955 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kourosh Lotfi Sweden 18 400 383 283 264 141 54 968
Monica Pallis United Kingdom 23 674 1.7× 590 1.5× 168 0.6× 509 1.9× 158 1.1× 61 1.3k
Patrick Hayden Ireland 19 558 1.4× 415 1.1× 144 0.5× 346 1.3× 63 0.4× 53 996
Margarete Zaborski Germany 20 660 1.6× 608 1.6× 346 1.2× 306 1.2× 116 0.8× 43 1.5k
Kumiko Goi Japan 21 665 1.7× 341 0.9× 148 0.5× 356 1.3× 262 1.9× 78 1.2k
Ravindran Ankathil Malaysia 22 649 1.6× 225 0.6× 174 0.6× 318 1.2× 111 0.8× 99 1.3k
Carolyn Grove Australia 14 721 1.8× 772 2.0× 295 1.0× 128 0.5× 84 0.6× 29 1.3k
Simon Bomken United Kingdom 13 376 0.9× 234 0.6× 93 0.3× 366 1.4× 202 1.4× 32 964
Francesca Arruga Italy 20 502 1.3× 394 1.0× 550 1.9× 312 1.2× 94 0.7× 60 1.3k
Ruud Oerlemans Netherlands 13 583 1.5× 305 0.8× 79 0.3× 445 1.7× 75 0.5× 23 1.2k

Countries citing papers authored by Kourosh Lotfi

Since Specialization
Citations

This map shows the geographic impact of Kourosh Lotfi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kourosh Lotfi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kourosh Lotfi more than expected).

Fields of papers citing papers by Kourosh Lotfi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kourosh Lotfi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kourosh Lotfi. The network helps show where Kourosh Lotfi may publish in the future.

Co-authorship network of co-authors of Kourosh Lotfi

This figure shows the co-authorship network connecting the top 25 collaborators of Kourosh Lotfi. A scholar is included among the top collaborators of Kourosh Lotfi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kourosh Lotfi. Kourosh Lotfi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thiele, Thomas, Stefan Handtke, Johannes Rath, et al.. (2023). PB1338 Thrombotic Thrombocytopenia Syndrome after vaccination against COVID-19 Associated with Antiplatelet Antibodies. Research and Practice in Thrombosis and Haemostasis. 7. 101447–101447. 1 indexed citations
2.
3.
Richter, Johan, Anna Lübking, Stina Söderlund, et al.. (2021). Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR—final report from AFTER-SKI. Leukemia. 35(8). 2416–2418. 16 indexed citations
4.
Malyukova, Alena, Dorina Ujvári, Márton Keszei, et al.. (2021). Combination of tyrosine kinase inhibitors and the MCL1 inhibitor S63845 exerts synergistic antitumorigenic effects on CML cells. Cell Death and Disease. 12(10). 875–875. 10 indexed citations
5.
6.
Ingelsson, Björn, Daniel Söderberg, Tobias Strid, et al.. (2018). Lymphocytes eject interferogenic mitochondrial DNA webs in response to CpG and non-CpG oligodeoxynucleotides of class C. Proceedings of the National Academy of Sciences. 115(3). E478–E487. 100 indexed citations
7.
8.
Kreutzman, Anna, Perttu Koskenvesa, Tiina Kasanen, et al.. (2016). Immunological Monitoring of CML Patients during First-Line Bosutinib and Imatinib Treatment. Blood. 128(22). 3069–3069. 1 indexed citations
9.
Boknäs, Niklas, et al.. (2016). PO-55 - Individual variation in hemostatic alterations caused by tyrosine kinase inhibitors – a way to improve personalized cancer therapy?. Thrombosis Research. 140. S196–S197. 4 indexed citations
10.
11.
Skoglund, Karin, Johan Richter, Ulla Olsson‐Strömberg, et al.. (2015). In Vivo Cytochrome P450 3A Isoenzyme Activity and Pharmacokinetics of Imatinib in Relation to Therapeutic Outcome in Patients With Chronic Myeloid Leukemia. Therapeutic Drug Monitoring. 38(2). 230–238. 10 indexed citations
12.
Willander, Kerstin, Ingrid Jakobsen Falk, Roza Chaireti, et al.. (2014). Mutations in the isocitrate dehydrogenase 2 gene and IDH1 SNP 105C > T have a prognostic value in acute myeloid leukemia. Biomarker Research. 2(1). 18–18. 32 indexed citations
13.
Falk, Ingrid Jakobsen, Hareth Nahi, Monica Hermanson, et al.. (2013). Decreased survival in normal karyotype AML with single‐nucleotide polymorphisms in genes encoding the AraC metabolizing enzymes cytidine deaminase and 5′‐nucleotidase. American Journal of Hematology. 88(12). 1001–1006. 27 indexed citations
14.
Skoglund, Karin, et al.. (2012). A potential role of fetal hemoglobin in the development of multidrug resistance. Biochemical and Biophysical Research Communications. 427(3). 456–460. 1 indexed citations
15.
Börjeson, Sussanne, et al.. (2010). A prospective evaluation of patients' health-related quality of life during auto-SCT: a 3-year follow-up. Bone Marrow Transplantation. 46(10). 1345–1352. 39 indexed citations
16.
Eriksson, Andreas, Kourosh Lotfi, & Per A Whiss. (2010). Enhanced platelet adhesion in essential thrombocythemia after in vitro activation. Turkish Journal of Hematology. 27(2). 82–90.
17.
Albertioni, Freidoun, et al.. (2008). RNAi Depletion of Deoxycytidine and Deoxyguanosine Kinase in Human Leukemic CEM Cells. Nucleosides Nucleotides & Nucleic Acids. 27(6-7). 712–719. 1 indexed citations
18.
Albertioni, Freidoun, et al.. (2007). Cell cycle effect on the activity of deoxynucleoside analogue metabolising enzymes. Biochemical and Biophysical Research Communications. 357(4). 847–853. 10 indexed citations
19.
Gréen, Henrik, et al.. (2003). Spontaneous Reversal of P‐Glycoprotein Expression in Multidrug Resistant Cell Lines*. Pharmacology & Toxicology. 93(6). 297–304. 9 indexed citations
20.
Lotfi, Kourosh, Joya Chandra, Yuying Wang, et al.. (2001). Pharmacological basis for cladribine resistance in a human acute T lymphoblastic leukaemia cell line selected for resistance to etoposide. British Journal of Haematology. 113(2). 339–346. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monica Pallis Breakdown of academic impact, for papers by Patrick Hayden Breakdown of academic impact, for papers by Margarete Zaborski Breakdown of academic impact, for papers by Kumiko Goi Breakdown of academic impact, for papers by Ravindran Ankathil Breakdown of academic impact, for papers by Carolyn Grove Breakdown of academic impact, for papers by Simon Bomken Breakdown of academic impact, for papers by Francesca Arruga Breakdown of academic impact, for papers by Ruud Oerlemans
Rankless by CCL
2026